Pharmaceuticals
Asia-Pacific Neuropathic Pain Market to 2032
Revenue, 2024 ()
1,052.09
Forecast, 2032 ()
2,339.30
CAGR, 2024 - 2032
10.26%
Report Coverage
Asia-Pacific
Asia-Pacific Neuropathic Pain Market 2018-2032
Asia-Pacific Neuropathic Pain Market, Overview (2024-2032)
Market Growth and Projections:
- Market Size (2024): 1,052.09
- Projected Market Size (2032): 2,339.30
- CAGR (2024-2032): 10.26%
Key Findings of Asia-Pacific Neuropathic Pain Market
- The Asia-Pacific Neuropathic Pain Market is likely to grow at a CAGR of 10.26% during the forecast period of 2024 to 2032.
- Asia-Pacific Neuropathic Pain Marketsize was valued at 1,052.09 in 2024.
- In 2024, Prescription-Based Devices segment dominated the market with the largest market share.
- Peripheral Neuropathy in the product segment is expected to witness the fastest growth during the forecast period.
Asia-Pacific Neuropathic Pain Market Scope
Asia-Pacific Neuropathic Pain Market Segmentation & Scope
Modality
- Stationary
- Portable
Mode of Purchase
- Over-The-Counter Devices
- Prescription-Based Devices
Pain Type
- Coccydynia
- Trigeminal Neuralgia
- Foot Pain
- Others
- Entrapment Neuropathy
- Post Traumatic Neuropathy
- Post Herpetic Neuralgia (PHN)
- Phantom Limb Pain
- Peripheral Neuropathy
Indication
- Others
- Chemotherapy-Induced Peripheral Neuropathy
- Diabetic Neuropathy
- Spinal Stenosis
Technology
- Respiratory Electrical Stimulation
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Nerve Stimulation
Type
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- External Peripheral Nerve Stimulation
- Spinal Cord Stimulation (SCS) Devices
Product Type
- Non-Rechargeable
- Rechargeable
Procedure
- Invasive
- Non-Invasive
End User
- Others
- Ambulatory Surgical Centers
- Home Healthcare
- Hospitals
- Clinics
Distribution Channel
- Others
- Third Party Distribution
- Direct Tenders
Asia-Pacific Neuropathic Pain Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in |
| Market Value in 2024 | 1,052.09 |
| Market Value in 2032 | 2,339.30 |
| CAGR (2024-2032) | 10.26% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Modality,Mode of Purchase,Pain Type,Indication,Technology,Type,Product Type,Procedure,End User,Distribution Channel |
| Largest Segment | Prescription-Based Devices |
| Fastest Growing Segment | Peripheral Neuropathy |
| Major Players | Medtronic, Omron Healthcare, Inc., NEVRO CORP., Integer Holdings Corporation, Boston Scientific Corporation or its affiliates, Abbott, Others |
Market Segmentation:
-
Product Segment:
- Largest Segment (2024): Prescription-Based Devices
- Fastest Growing Segment (2024-2032): Peripheral Neuropathy
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific
- Key Country: China, leading in terms of revenue and market share by 2032.
Asia-Pacific Neuropathic Pain Market Company Share Analysis
| Name | Market Share | OwnnerShip | HQ | Website |
|---|---|---|---|---|
| Medtronic | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Omron Healthcare | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Inc. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| NEVRO CORP. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Integer Holdings Corporation | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Boston Scientific Corporation or its affiliates | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Abbott | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Others | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
Asia-Pacific Neuropathic Pain Market Geographical Sales Distribution, 2018-2032
Asia-Pacific Neuropathic Pain Market Company Profiling
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
Frequently Asked Questions
The Asia-Pacific Neuropathic Pain Market is segmented based on Segmentation Modality,Mode of Purchase,Pain Type,Indication,Technology,Type,Product Type,Procedure,End User,Distribution Channel.
Asia-Pacific Neuropathic Pain Market was valued at USD 1,052.09(Revenue in ) in 2020.
Asia-Pacific Neuropathic Pain Market is projected to grow at a CAGR of 10.26% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Neuropathic Pain Market for final year is USD 2,339.30 ().
Related Markets
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.